Published in Obesity and Diabetes Week, July 28th, 2008
"We have assessed the impact of weight loss on glucocorticoid secretion and metabolism (notably 11 beta-hydroxysteroid dehydrogenase type 1 and 5 alpha-reductase [5 alpha R] activity) and insulin sensitivity. Twenty obese volunteers were investigated before and after weight loss. Patients underwent hyperinsulinemic-euglycemic clamps with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.